Brief: Nanexa And Novo Enter Global License, Collaboration Deal
25/09/2026 07:56
BRIEF-Nanexa And Novo Enter Global License, Collaboration Deal Sept 25 (Reuters) - Nanexa AB NANEXA.ST:
SAID ON THURSDAY CO AND NOVO NORDISK ENTER GLOBAL LICENSE, COLLABORATION DEAL WORTH UP TO EUR 1.165 BLN
DEAL COVERS UP TO FIVE PROGRAMS, TARGETS MONTHLY AND QUARTERLY DOSING FOR OBESITY, DIABETES DRUGS
EUR 615 MLN OF DEAL VALUE COMPRISES UPFRONT, DEVELOPMENT AND REGULATORY MILESTONES
Source text for Workspace: nMFNc51q1r
Further company coverage: NANEXA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Nanexa AB
See all newsNanexa shares soar on €1.17 billion Novo Nordisk deal for injection technology
Brief: Nanexa And Novo Enter Global License, Collaboration Deal
Brief: Forge Nano And Nanexa To Develop Gmp-Compatible Ald Manufacturing Equipment
Brief: Nanexa Q2 Revenue Amounted To SEK 1.7 Million
Sweden's Nanexa Q1 revenue falls, loss widens